BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17878632)

  • 1. Detection of mRNAs of GA733 genes by RT-PCR in exfoliated cells of pleural and peritoneal effusions and its clinical values.
    Zhang KH; Cao F; Fu QB; Zhu JQ; Chen J; Lv NH
    Intern Med; 2007; 46(18):1489-94. PubMed ID: 17878632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time reverse transcription-polymerase chain reaction assay for GA733-2 mRNA in the detection of metastatic carcinoma cells in serous effusions.
    Nagel H; Werner C; Hemmerlein B
    Am J Clin Pathol; 2003 Dec; 120(6):888-901. PubMed ID: 14671978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of malignant serous effusions diagnosis by quantitative analysis of molecular claudin 4 expression.
    Mohamed F; Vincent N; Cottier M; Peoc'h M; Merrouche Y; Patouillard B; Paul S; Genin C
    Biomarkers; 2010 Jun; 15(4):315-24. PubMed ID: 20175704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic significance of the detection of cytokeratin 19 mRNA by quantitative RT-PCR in benign and malignant pleural effusions.
    Xu F; Chen J; Shen HH; Wang XD; Shan J
    J Zhejiang Univ Sci; 2004 Oct; 5(10):1286-9. PubMed ID: 15362202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of CEA mRNA detection in pleural and peritoneal effusions by real-time fluorescent quantitative RT-PCR].
    Zhang X; Cao J; Zheng S; Li XF
    Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):411-3. PubMed ID: 12895345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions.
    Passebosc-Faure K; Li G; Lambert C; Cottier M; Gentil-Perret A; Fournel P; Pérol M; Genin C
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6862-7. PubMed ID: 16203775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of the FHIT and p16 mRNA loss and the K-ras gene mutation in pleural fluids for malignant pleural effusion.
    Li J; Bao QL; Wang Y; Hu YM; Chen P
    Cancer Biomark; 2013; 13(1):49-58. PubMed ID: 23736021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
    Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of the detection of the homozygous deletion of P16 gene in malignant pleural effusion.
    Gui S; Liu H; Zhang L; Zuo L; Zhou Q; Fei G; Wang Y
    Intern Med; 2007; 46(15):1161-6. PubMed ID: 17675763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.
    Roncella S; Ferro P; Bacigalupo B; Dessanti P; Pronzato P; Franceschini MC; Pratticò L; Carletti AM; Canessa PA; Fontana V; Fais F; Pistillo MP; Fedeli F
    Diagn Mol Pathol; 2008 Mar; 17(1):28-33. PubMed ID: 18303409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a sensitive, specific reverse transcriptase polymerase chain reaction-based assay for epithelial tumour cells in effusions.
    Sakaguchi M; Virmani AK; Ashfaq R; Rogers TE; Rathi A; Liu Y; Kodagoda D; Cunningham HT; Gazdar AF
    Br J Cancer; 1999 Feb; 79(3-4):416-22. PubMed ID: 10027307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions.
    Wang T; Qian X; Wang Z; Wang L; Yu L; Ding Y; Liu B
    Int J Cancer; 2009 Oct; 125(8):1921-5. PubMed ID: 19585499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different expression of FoxM1 in human benign and malignant pleural effusion.
    Tang Z; Li H; Zhu H; Bai C
    Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of p53 and ki67 immunostaining for distinguishing benign from malignant serous effusions.
    Hafez NH; Tahoun NS
    J Egypt Natl Canc Inst; 2011 Dec; 23(4):155-62. PubMed ID: 22776843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion.
    Sun W; Li J; Jiang HG; Ge LP; Wang Y
    QJM; 2014 Dec; 107(12):1001-7. PubMed ID: 24939190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 expression in ovarian carcinoma is MDR1 independent.
    Davidson B; Goldberg I; Givant-Horwitz V; Nesland JM; Berner A; Bryne M; Risberg B; Kopolovic J; Kristensen GB; Tropé CG; van de Putte G; Reich R
    Am J Clin Pathol; 2002 Feb; 117(2):225-34. PubMed ID: 11863219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma.
    Sergeant G; Roskams T; van Pelt J; Houtmeyers F; Aerts R; Topal B
    BMC Cancer; 2011 Jan; 11():47. PubMed ID: 21281486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
    Fiegl M; Haun M; Massoner A; Krugmann J; Müller-Holzner E; Hack R; Hilbe W; Marth C; Duba HC; Gastl G; Grünewald K
    J Clin Oncol; 2004 Feb; 22(3):474-83. PubMed ID: 14752070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions.
    He DN; Zhu HS; Zhang KH; Jin WJ; Zhu WM; Li N; Li JS
    World J Gastroenterol; 2004 Aug; 10(16):2406-8. PubMed ID: 15285029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow.
    Zhong XY; Kaul S; Eichler A; Bastert G
    Arch Gynecol Obstet; 1999 Nov; 263(1-2):2-6. PubMed ID: 10728619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.